Back to Journals » Open Access Journal of Clinical Trials » Volume 3
Original Research
Phase II trial of second-line erlotinib and digoxin for nonsmall cell lung cancer (NSCLC)
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,373 | Dovepress* | 9,373+ | 2,287 | 11,660 | |
Totals | 9,373 | 2,287 | 11,660 | ||
*Since 6 February 2011 +Since July 2016 |
View citations on Google Scholar